Bluestar Genomics Bluestar Genomics develops non-invasive tests to detect cancer through a standard blood draw earlier than existing methods by harnessing the power of epigenomics. We partnered with 22 Fillmore, a brand consultancy in the Bay Area, to deliver a full...
CTI BioPharma CTI is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers. We partnered with 22 Fillmore, a brand consultancy in the Bay Area, to deliver a full corporate...
Theseus Pharmaceuticals Theseus Pharmaceuticals is a company developing pan-variant tyrosine kinase inhibitors (TKIs) designed to overcome treatment-resistant cancer mutations. We partnered with 22 Fillmore, a brand consultancy in the Bay Area, to deliver a full...
Day One Bio Day One Biopharmaceuticals is a company created to find and develop new therapies that meet the critical needs of people of all ages living with cancer – starting from the biology of childhood cancer. We partnered with 22 Fillmore, a brand consultancy in...
Akero Therapeutics Akero Therapeutics is a cardio-metabolic biotechnology company developing transformational treatments for non-alcoholic steatohepatitis (NASH). We partnered with 22 Fillmore, a brand consultancy in the Bay Area, to deliver a full corporate rebrand...
